Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001770390 | SCV001993778 | uncertain significance | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation, as the last 43 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 29068549) |
Labcorp Genetics |
RCV002231194 | SCV002509017 | pathogenic | Short-rib thoracic dysplasia 11 with or without polydactyly | 2024-09-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln494*) in the WDR34 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 43 amino acid(s) of the WDR34 protein. This variant is present in population databases (rs751323441, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with asphyxiating thoracic dystrophy (PMID: 29068549). ClinVar contains an entry for this variant (Variation ID: 446621). This variant disrupts a region of the WDR34 protein in which other variant(s) (p.Thr514Argfs*11) have been determined to be pathogenic (PMID: 24183451). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Dan Cohn Lab, |
RCV000515944 | SCV000612026 | pathogenic | Jeune thoracic dystrophy | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV000515944 | SCV001479903 | likely pathogenic | Jeune thoracic dystrophy | no assertion criteria provided | research |